7774 J . Org. Chem., Vol. 66, No. 23, 2001
Hecht et al.
The resulting [1-3H]4 played a crucial role in the iden-
tification of the ispD gene of the non-mevalonate path-
way.15 Two more synthetic procedures for the preparation
of 4 have been published so far that allow the introduc-
tion of stable isotope labels.9,19 However, in general,
chemical syntheses of multiply labeled compounds need
specific strategies and numerous reaction and isolation
steps in contrast to the universality of our enzymatic
approach.
In comparison to chemical syntheses, the procedures
in this paper have the combined advantages of (i) a high
yield, (ii) short reaction times, (iii) access to a virtually
unlimited variety of 13C- or 14C-isotopomers from com-
mercially available precursors, (iv) virtually perfect ste-
reocontrol, (v) the simplicity of the one-pot reaction
conditions in aqueous solution, (vi) the possibility of real-
time monitoring of the reaction progress by NMR, (vi)
the use of commercially available enzymes for all but two
reaction steps, and (vii) the exclusive use of starting
materials that are commercially available.
It should be mentioned that these favorable aspects
of “long shot” in vitro biotransformation are not in any
way limited to the biosynthesis of terpenoids. Similar
synthetic strategies could be used for a wide variety
of natural products in an isotope-labeled or unlabeled
form. The rapidly growing body of genomic data from a
wide variety of organisms, the advanced state of re-
combinant DNA technology, and the specific design of
recombinant enzymes for ease of purification provide a
steadily improving framework for the generalization of
this approach.
enzymes. The ligation mixture was electroporated into E. coli
XL1-Blue and M15 [pREP4] cells affording the recombinant
strains XL1-pQEYAEMECO and M15-pQEYAEMECO, re-
spectively.
Sequ en ce Deter m in a tion . DNA sequencing was per-
formed by the automated dideoxynucleotide method.21 N-
Terminal peptide sequences were obtained by the pulsed-liquid
mode.
P u r ifica tion of Recom bin a n t 2C-Meth yl-D-er yth r itol
4-P h osp h a te Syn th a se fr om E. coli. Recombinant E. coli
M15-pQEYAEMECO cells (2 g) were suspended in 25 mL of
buffer A (100 mM Tris hydrochloride (pH 8.0), 0.5 M sodium
chloride) containing 20 mM imidazole hydrochloride, 25 mg
of lysozyme, and 2.5 mg of DNase I. The mixture was
incubated at 37 °C for 30 min, cooled on ice, and subjected to
ultrasonic treatment. The suspension was centrifuged at
15 000 rpm for 30 min. The supernatant was loaded on a Ni2+
-
chelating Sepharose column (2 × 8 cm) at a flow rate of 3 mL/
min, which had been equilibrated with 20 mM imidazole in
buffer A. The column was developed with a linear gradient of
20-500 mM imidazole in buffer A (total volume ) 300 mL).
Fractions were combined and concentrated by ultrafiltration.
Assa y of 2C-Met h yl-D-er yt h r it ol 4-P h osp h a t e Syn -
th a se. 2C-Methyl-D-erythritol 4-phosphate synthase was as-
sayed according to Takahashi et al.1
An a lytica l Ultr a cen tr ifu ga tion . The concentrated protein
from the purification step described above was loaded on top
of a Superdex 75 HR 26/60 column, which had been equili-
brated with 100 mM Tris hydrochloride (pH 8.0) containing 1
mM dithiothreitol, 0.02% sodium azide, and 50 mM sodium
chloride at a flow rate of 3 mL/min. 2C-Methyl-D-erythritol
4-phosphate synthase was eluted to a volume of 132 mL. The
peak fraction with an absorbance of about 1 OD at 280 nm
was used as a sample for analytical ultracentrifugation.
Hydrodynamic studies were performed with an analytical
ultracentrifuge Optima XL-1 (Beckman Coulter) equipped with
UV and interference optics. Experiments were performed with
double-sector cells equipped with aluminum centerpieces and
sapphire windows. Partial specific volumes and buffer densi-
ties were estimated according to published procedures.22
P r ep a r a tion of [2-13C1]2C-Meth yl-D-er yth r itol 4-P h os-
p h a te (P r oced u r e 1). A solution containing 440 mg (660
µmol) of dimeric dihydroxyacetone phosphate acetal (7) in
10 mL of water was added to a suspension of Dowex 50 WX8
(5 mL, H+ form). The mixture was incubated at 65 °C for 2 h.
The solid was filtered off and washed with water. The
combined solution was lyophilized. Dihydroxyacetone phos-
phate glass (242 mg, containing about 92 mg (0.33 mmol) of
8) was dissolved in 2.5 mL of water, and the pH was adjusted
to 8.0 by the addition of 8 M sodium hydroxide. A solution
(1.5 mL) containing 450 mM Tris hydrochloride (pH 8.0), 30
mM magnesium chloride, 8.5 mg (20 µmol) of thiamine
diphosphate, 1.5 mg (10 µmol) of dithiothreitol, and 363 mg
(330 µmol) of [2-13C1]pyruvate (1, sodium salt) was added. The
pH was adjusted to 8.0, and 88 units (15 µg) of triose phosphate
isomerase and 9.6 units (3.0 mg) of 1-deoxy-D-xylulose 5-phos-
phate synthase were added. The mixture was incubated at 37
°C for 11 h. NADPH (317 mg, 350 µmol) and 2C-methyl-D-
erythritol 4-phosphate synthase (1 mg) were added, and
incubation was continued at 37 °C for 2 h. The product was
purified by chromatography on ECTEOLA cellulose as de-
scribed below, yielding 43.6 mg (201 µmol, 61%).
Exp er im en ta l Section
Ma ter ia ls. The following materials were obtained from the
sources indicated in parentheses: 13C-labeled compounds
(Isotec, Miamisburg, OH); [1-3H]glucose (Amersham Pharma-
cia Biotech, Freiburg, Germany); sodium [2-14C]pyruvate
(NEN, Boston, MA); oligonucleotides (MWG Biotech, Ebers-
berg, Germany); T4 ligase (Gibco-BRL, Eggenstein, Germany);
Sepharose Q FF, Superdex 75 HR 26/60, and restriction
enzymes (Amersham Pharmacia Biotech); chemicals and
enzymes (Sigma Chemicals, Deisenhofen, Germany); DNase
I (Roche Diagnostics, Mannheim, Germany); Taq polymerase
and IPTG (Eurogentec, Seraing, Belgium); RNase A and
Nucleosil 10SB (16 × 250 mm) (Macherey & Nagel, Du¨ren,
Germany); ECTEOLA 23 cellulose (Fluka, Deisenhofen, Ger-
many); TLC plates (Merck, Darmstadt, Germany); and Ni2+
-
chelating Sepharose and Dowex ion exchangers (Amersham
Pharmacia, Braunschweig, Germany). 1-Deoxy-D-xylulose
5-phosphate was prepared as described elsewhere.20
P r ot ein s. The preparation of recombinant 1-deoxy-D-
xylulose 5-phosphate synthase from Bacillus subtilis has been
reported elsewhere.20
Micr oor ga n ism s a n d P la sm id s. Bacterial strains and
plasmids used in this study are summarized in Table 1.
Con str u ction of a n Exp r ession P la sm id . The ispC gene
of E. coli coding for 2C-methyl-D-erythritol 4-phosphate syn-
thase (GenBank accession no. AE000126) was amplified from
base pair position 9887 to 11 083 by PCR using the oligo-
nucleotides ECOYAEM1 (5′-ggaggatccatgaagcaactcacc-3′) and
ECOYAEM2 (5′-gcgcgactctctgcagccgg-3′) as primers and chro-
mosomal E. coli DNA as the template. The amplificate was
digested with the restriction endonucleases BamHI and PstI.
The fragment was ligated into the expression plasmid vector
pQE30, which had been digested with the same restriction
P u r ifica tion of 2C-Meth yl-D-er yth r itol 4-P h osp h a te
(Gen er a l P r oced u r e). Crude reaction mixtures obtained as
described above were lyophilized. The crude product was
(21) Sanger, F.; Nicklen, S.; Coulson, A. R. Proc. Acad. Natl. Sci.
U.S.A. 1977, 74, 5463-5468.
(22) Lane, T. M.; Shah, B. D.; Rigeway, R. M.; Pelltier, S. L. In
Analytical Ultracentrifugation in Biochemistry and Protein Science;
Harding, S. E., Rowe, A. J ., Horton, J . C., Eds.; Royal Society of
Chemistry: Cambridge, 1992; pp 90-125.
(23) Zahmenhof, P. J .; Villarejo, M. J . Bacteriol. 1972, 110, 171-
178.
(24) Bullock, W. O.; Fernandez, J . M.; Short, J . M. BioTechniques
1987, 5, 376-379.
(19) Fontana, A. J . Org. Chem. 2001, 66, 2506-2508.
(20) Hecht, S.; Kis, K.; Eisenreich, W.; Amslinger, S.; Wungsin-
taweekul, J .; Herz, S.; Rohdich, F.; Bacher, A. J . Org. Chem. 2001,
66, 3948-3952.